Thursday, February 7, 2013

Evoluation of Indian Anti-Infective Market : 2007 - 2012

The Anti-Infective category which is the largest therapy area in the Indian prescription drug market has grown at 12 percent CAGR from 2007 to 2012. Ranbaxy, Alkem and Aristo dominate the anti-infective formulation space. Among the  pure play API manufacturer Nectar and Surya Pharma used to be the larger ones, but with the bankruptcy of Surya Pharma, Nectar has gained further strength.


Enter your email address:

Delivered by FeedBurner

No comments:

Post a Comment